酸基酸基架:制造,特征和药物输送潜力
Teodora Jakovljević1, Jelena Stanisavljević2,3, Julijana Stevanović4
1Innovation Center of the Faculty of Technology and Metallurgy Ltd., University of Belgrade, Karnegijeva 4, 11000 Belgrade, Serbia.
Biomedicines
|September 27, 2025
概括
这项研究开发了多离子化酸基架,用酸盐涂层用于骨再生和药物输送. 这种新型生物材料平台表现出机械稳定性和抗癌氨化合物的持续释放.
科学领域:
- 生物材料科学 生物材料科学
- 材料化学 材料化学
- 生物医学工程 生物医学工程
背景情况:
- 生物材料的进步对于硬组织再生和可控的药物输送至关重要.
- 酸 (HAp) 支架为生物医学应用提供了有前途的特性.
- 酸盐涂层可以提高生物材料的稳定性和功能性.
研究的目的:
- 开发用于局部药物输送的多离子化HAp支架,采用基托基涂层.
- 将一种具有潜在抗癌活性的新型化化合物纳入.
- 评估这些支架对于骨组织工程和癌症治疗的适用性.
主要方法:
- 通过热水方法合成多离子合的HAp粉末 (Mg2+,Sr2+,F-).
- 采用海绵复制技术制造的支架,并涂上奇多或奇多-化混合物.
- 分析了脚手架的特性,包括机械强度,生物活性,细胞毒性和药物释放概况.
主要成果:
- 确认了Mg2 +,Sr2 +和F-dopants的成功整合.
- 酸盐涂层增强了脚手架的压力强度和降低了降解率.
- 化化合物显示剂量依赖的抗瘤细胞毒性和持续释放长达15天.
结论:
- 多离子化HAp脚手架与奇托-酸涂层显示了骨组织工程的潜力.
- 开发的平台可以实现局部,持续的抗癌药物输送.
- 这种组合为硬组织再生和向癌症治疗提供了有希望的方法.
相关概念视频
Drug Delivery: Overview
1.3K
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
1.3K
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
332
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
332
Biopharmaceutical Factors Influencing Drug Product Design: Overview
547
Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though...
547
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Production of Pharmaceuticals
94
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
94


